natgillin/translations-raw huggingface dataset:
The active substance in Humira, adalimumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a chemical messenger in the body called tumour necrosis factor (TNF).
Djelatna tvar u lijeku Humira je adalimumab, monoklonsko protutijelo (vrsta proteina) namijenjeno prepoznavanju i vezivanju za kemijski glasnik u tijelu zvan faktor tumorske nekroze (TNF).
The active substance in Hycamtin, topotecan, is a cancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Djelatna tvar lijeka Hycamtin, topotekan, je protutumorski lijek koji se ubraja u grupu „inhibitora topoisomeraze".
The active substance in Iclusig, ponatinib, belongs to a group of medicines called ‘tyrosine kinase inhibitors’.
Djelatna tvar u lijeku Iclusig, ponatinib, pripada skupini lijekova zvanih „inhibitorni tirozin kinaze”.
The active substance in IDELVION is albutrepenonacog alfa (recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP)).
Djelatna tvar u lijeku IDELVION je albutrepenonakog alfa(rekombinantni fuzijski protein koagulacijskog faktora IX i albumina [rIX-FP]).
The active substance in Idelvion, albutrepenonacog alfa, works in the body in the same way as human factor IX.
Djelatna tvar lijeka Idelvion, albutrepenonakog alfa, djeluje u tijelu jednako kao ljudski faktor IX.
The active substance in Ifirmasta, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Irbesartan, djelatna tvar u lijeku Ifirmasta je „antagonist receptora angiotenzina II”, što znači da ova tvar blokira djelovanje hormona u tijelu naziva angiotenzin II.
The active substance in Ikervis, ciclosporin, acts on cells of the immune system (the body’s natural defences) that are involved in the processes that cause inflammation.
Djelatna tvar lijeka Ikervis, ciklosporin, djeluje na stanice imunosnog sustava (prirodnu obranu tijela) koja je uključena u postupke koji uzrokuju upalu.
The active substance in Ilaris, canakinumab, is a monoclonal antibody, a type of protein that has been designed to recognise and attach to a specific structure (called an antigen) that is found on certain cells in the body.
Djelatna tvar u lijeku Ilaris, kanakinumab, monoklonsko je protutijelo, tj. vrsta proteina namijenjena prepoznavanju i vezivanju na specifičnu strukturu (antigen) koja se nalazi u određenim stanicama u tijelu.
The active substance in Imatinib Accord, imatinib, is a protein-tyrosine kinase inhibitor.
Djelatna tvar lijeka Imatinib Accord, imatinib, je inhibitor protein-tirozin kinaze.
The active substance in Imatinib Actavis, imatinib, is a protein-tyrosine-kinase inhibitor.
Djelatna tvar lijeka Imatinib Actavis, imatinib, je inhibitor protein-tirozin kinaze.
The active substance in Imbruvica, ibrutinib, works by blocking an enzyme called Bruton’s tyrosine kinase (Btk), which is mostly found in B lymphocytes.
Djelatna tvar lijeka Imbruvica, ibrutinib, djeluje inhibirajući enzime naziva Brutonove tirozin kinaze (Btk), koji su u najvećem broju prisutni u B-limfocitima.
The active substance in Imnovid, pomalidomide, is an immunomodulating agent.
Djelatna tvar u Imnovid, pomalidomid, je imunomodulatorni agens.
The active substance in Imrestor 15 mg solution for injection for cattle is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatna tvar u lijeku Imrestor 15 mg otopina za injekcije za goveda je dozvoljena tvar kako je navedeno u tablici 1, Dodatka Uredbe Komisije (EU) br.
The active substance in Incruse, umeclidinium bromide, is a muscarinic receptor antagonist.
Djelatna tvar lijeka Incruse, umeklidinijev bromid, antagonist je muskarinskih receptora.
The active substance in InductOs is dibotermin alfa (also called recombinant human Bone Morphogenetic Protein-2), 4 mg (4 mg pack) or 12 mg (12 mg pack).
Djelatna tvar u lijeku InductOs je dibotermin alfa (koji se još naziva rekombinantni humani koštani morfogenetski protein-2), 4 mg (pakiranje od 4 mg) ili 12 mg (pakiranje od 12 mg).
The active substance in Inhixa, enoxaparin, is one of a group of anticoagulant medicines called ‘low-molecular weight heparins’.
Djelatna tvar lijeka Inhixa, enoksaparin, pripada skupini antikoagulansa naziva „heparini niske molekularne težine”.
The active substance in Inlyta, axitinib, works by blocking some enzymes known as tyrosine kinases that are found in ‘vascular endothelial growth factor’ (VEGF) receptors on the surface of cancer cells.
Djelatna tvar lijeka Inlyta, aksitinib, djeluje inhibirajući određene enzime poznate pod nazivom tirozin kinaze koji su prisutni u receptorima krvožilnog endotelnog faktora rasta (VEGFR) na površini stanica raka.
The active substance in Intelence, etravirine, is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Djelatna tvar lijeka Intelence, etravirin, je nenukleozidni inhibitor povratne transkriptaze (NNRTI).
The active substance in Invega, paliperidone, is an antipsychotic medicine.
Djelatna tvar lijeka Invega, paliperidon, je antipsihotik.
The active substance in Invirase, saquinavir, is a ‘protease inhibitor’.
Djelatna tvar u lijeku Invirase, sakvinavir, je „inhibitor proteaze”.
The active substance in Irbesartan Zentiva, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Irbesartan, djelatna tvar u lijeku Irbesartan Zentiva je „antagonist receptora angiotenzina II”, što znači da ova tvar blokira djelovanje hormona u tijelu naziva angiotenzin II.
The active substance in Isentress, raltegravir, is an integrase inhibitor.
Djelatna tvar lijeka Isentress, raltegravir, je inhibitor integraze.
The active substance in Ivabradine Anpharm, ivabradine, works by blocking the ‘If currents’ in the sinus node, the natural ‘pacemaker’ that controls the heart’s contractions and regulates the heart rate.
Djelatna tvar u lijeku Ivabradine Anpharm , ivabradin, djeluje inhibirajući „If struje” u sinusnom čvoru, „predvodniku” za srce koji kontrolira kontrakcije srca i regulira frekvenciju srca.
The active substance in Izba, travoprost, is a prostaglandin analogue (a man-made version of a prostaglandin, substances naturally found in the body).
Djelatna tvar u lijeku Izba, travoprost, analog je prostaglandina (umjetna inačica prostaglandina, tvari koja se prirodno nalazi u tijelu).
The active substance in Jardiance, empagliflozin, works by blocking a protein in the kidneys called sodium-glucose co-transporter 2 (SGLT2).
Djelatna tvar u lijeku Jardiance, empagliflozin, djeluje blokadom proteina u bubrezima zvanih kotransporter 2 natrija i glukoze (SGLT2).
The active substance in Jetrea, ocriplasmin, is similar to human plasmin, a naturally occurring enzyme in the eye which is capable of breaking down proteins between the vitreous humour and the retina which are responsible for the adhesion, thereby reducing retinal swelling and improving vision.
Djelatna tvar lijeka Jetrea, okriplazmin, sličan je ljudskom plazminu, enzimu koji se prirodno pojavljuje u oku, a koji može razgrađivati proteine između staklastog tijela i mrežnice koji su odgovorni za adheziju, te stoga smanjuje oticanje mrežnice i poboljšava vid.
The active substance in Jevtana, cabazitaxel, belongs to the group of cancer medicines known as ‘taxanes’.
Djelatna tvar lijeka Jevtana, kabazitaksel, ubraja se u skupinu lijekova protiv raka pod nazivom "taksani".
The active substance in Jinarc, tolvaptan, is a vasopressin-2-receptor antagonist: it works by blocking receptors in the kidneys to which the hormone vasopressin attaches.
Djelatna tvar lijeka Jinarc, tolvaptan, je antagonist vazopresin-2-receptora: djeluje inhibirajući receptore u bubrezima na koje se vezuje hormon vazopresin.
The active substance in Kalydeco, ivacaftor, increases the activity of the defective channels in patients with the mutations G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R or R117H.
Djelatna tvar lijeka Kalydeco, ivakaftor, povećava aktivnost oštećenih kanala u bolesnika s mutacijama G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R ili R117H.
The active substance in Karvea, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Irbesartan, djelatna tvar u lijeku Karvea je „antagonist receptora angiotenzina II”, što znači da ova tvar blokira djelovanje hormona u tijelu naziva angiotenzin II.
The active substance in Keytruda, pembrolizumab, is a monoclonal antibody.
Djelatna tvar lijeka Keytruda, pembrolizumab, monoklonsko je protutijelo.
The active substance in Kineret, anakinra, is a copy of a natural human protein called ‘human interleukin 1 receptor antagonist’.
Djelatna tvar lijeka Kineret, anakinra, kopija je prirodnog humanog proteina naziva „antagonist receptora humanog interleukina 1”.
The active substance in Kineret, anakinra, is an immunosuppressive medicine (a medicine that reduces the activity of the immune system).
Djelatna tvar lijeka Kineret, anakinra, je imunosupresiv (lijek koji smanjuje aktivnost imunosnog sustava).
The active substance in Kinzalmono, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Telmisartan, djelatna tvar u lijeku Kinzalmono, „antagonist je receptora angiotenzina II”, što znači da u tijelu blokira djelovanje hormona naziva angiotenzin II.
The active substance in Kiovig, human normal immunoglobulin, is a highly purified protein extracted from human plasma (part of the blood).
Djelatna tvar u lijeku Kiovig, normalni ljudski imunoglobulin, iznimno je pročišćen protein ekstrahiran iz ljudske plazme (dijela krvi).
The active substance in Kisplyx, lenvatinib, is a ‘tyrosine-kinase inhibitor’.
Djelatna tvar lijeka Kisplyx, lenvatinib, inhibitor je tirozin kinaze.
The active substance in Kuvan, sapropterin dihydrochloride, is a synthetic copy of BH4.
Djelatna tvar u lijeku Kuvan, sapropterin dihidroklorid, je sintetička kopija BH4.
The active substance in Lartruvo, olaratumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a protein called ‘platelet-derived growth factor receptor alpha’ (PDGFRα).
Djelatna tvar lijeka Lartruvo, olaratumab, monoklonsko je protutijelo (vrsta proteina) koje prepoznaje i veže se za protein pod nazivom „alfa receptor za faktor rasta koji potječe od trombocita” (PDGFRα).
The active substance in Leflunomide Winthrop, leflunomide, is an immunosuppressant.
Djelatna tvar lijeka Leflunomide Winthrop, leflunomid, je imunosupresivan lijek.
The active substance in Lenvima, lenvatinib, is a ‘tyrosine-kinase inhibitor’.
Djelatna tvar lijeka Lenvima, lenvatinib, inhibitor je tirozin kinaze.
The active substance in Libertek, roflumilast, belongs to a group of medicines called ‘phosphodiesterase type 4 (PDE4) inhibitors’.
Roflumilast, djelatna tvar u Liberteku, pripada skupini lijekova zvanih inhibitori fosfodiesteraze tipa 4 (PDE4).
The active substance in Liprolog, insulin lispro, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced, which makes them able to produce insulin lispro.
Djelatna tvar lijeka Liprolog, inzulin lispro, proizvodi se metodom poznatom pod nazivom „tehnologija rekombinatne DNK“: proizvode ga bakterije u koje je umetnut gen (DNK), zbog kojeg proizvode inzulin lispro.
The active substance in Lixiana, edoxaban, is a ‘factor Xa inhibitor’.
Djelatna tvar lijeka Lixiana, edoksaban, inhibitor je faktora Xa.
The active substance in Lojuxta, lomitapide, blocks the action of a substance in the body called ‘microsomal triglyceride transfer protein’, which is present in the cells of the liver and the gut.
Djelatna tvar u lijeku Lojuxta, lomitapid, blokira djelovanje tvari u organizmu zvane „mikrosomalni protein za prijenos triglicerida” koji je prisutan u stanicama jetre i želuca.
The active substance in Lonquex, lipegfilgrastim, is similar to granulocyte colony stimulating factor (G‑CSF), a naturally occurring protein in the body that promotes the production of white blood cells including neutrophils in the bone marrow.
Djelatna tvar u lijeku Lonquex, lipegfilgrastim, sličan je čimbeniku koji potiče rast kolonija granulocita (G-CSF, eng. granulocyte colony stimulating factor), bjelančevine koja se prirodno nalazi u tijelu te potiče proizvodnju bijelih krvnih stanica uključujući neutrofile u koštanoj srži.
The active substance in Loxicom 20 mg/ml solution for injection for cattle, pigs and horses is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatna tvar u Loxicom 20 mg/ml otopini za injekciju za goveda, svinje i konje je dozvoljena tvar kako je navedeno u tablici 1, Dodatka Uredbe Komisije (EU) br.
The active substance in Loxicom is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010.
Djelatna tvar u lijeku Loxicom je dozvoljena tvar kako je navedeno u tablici 1, Dodatka Uredbe Komisije (EU) br.
The active substance in Lucentis, ranibizumab, is a small piece of a monoclonal antibody.
Djelatna tvar u lijeku Lucentis je ranibizumab, mali dio monoklonskog protutijela.
The active substance in Lumark, lutetium (177Lu) chloride, is a radioactive compound that mainly emits a type of radiation known as beta radiation, with small amounts of gamma radiation.
Djelatna tvar lijeka Lumark, lutecij (177Lu) klorid, je radioaktivni spoj koji uglavnom emitira tip zračenja poznat pod nazivom beta zračenje, s malom količinom gama zračenja.
The active substance in Lynparza, olaparib, blocks the action of enzymes called human poly (ADP ribose) polymerase (PARP), which help to repair damaged DNA in cells (both in normal and in cancer cells) during cell division.
Djelatna tvar lijeka Lynparza, olaparib, inhibira djelovanje enzima naziva humani poli (ADP riboza) polimeraza (PARP), koji pomaže u popravljanju oštećenja DNK u stanicama (kako u normalnih tako i u stanica raka) tijekom diobe stanica.
The active substance in Lyxumia, lixisenatide, is a ‘GLP-1 receptor agonist’.
Djelatna tvar u lijeku Lyxumia, liksisenatid je „agonist receptora GLP-1”.
The active substance in MabThera, rituximab, is a monoclonal antibody designed to recognise and attach to a protein called CD20 present on the surface of B-lymphocytes.
Djelatna tvar u lijeku MabThera je rituksimab, monoklonsko protutijelo, koje je osmišljeno za prepoznavanje i vezivanje na bjelančevinu naziva CD20, prisutnu na površini B-limfocita.
The active substance in MACI consists of the patient’s own cartilage cells, which are implanted into the cartilage defect in the knee.
Djelatna tvar u implantatu MACI sastoji se od bolesnikovih vlastitih stanica hrskavice, koje se usađuju u oštećenu hrskavicu koljena.
The active substance in Mekinist, trametinib, works by blocking MEK directly and by preventing its activation by BRAF thereby slowing down the growth and spread of the cancer.
Djelatna tvar u lijeku Mekinist, trametinib, djeluje izravno inhibirajući MEK i sprječavajući njegovo aktiviranje BRAF-om, te tako usporava rast i širenje raka.
The active substance in Melovem is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatna tvar u Melovem je dozvoljena tvar kako je navedeno u tablici 1, Dodatka Uredbe Komisije (EU) br.
The active substance in Meloxidolor is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatna tvar u Meloxidoloru je dozvoljena tvar kako je navedeno u tablici 1, Dodatka Uredbe Komisije (EU) br.
The active substance in Metacam is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatna tvar u Metacamu je dozvoljena tvar kako je navedeno u tablici 1, Dodatka Uredbe Komisije (EU) br.
The active substance in Metalyse, tenecteplase, is a modified copy of the human enzyme ‘tissue plasminogen activator’, which the body uses to break down clots.
Djelatna tvar lijeka Metalyse, tenekteplaza, modificirana je kopija humanog enzima „aktivatora tkivnog plazminogena”, koji tijelo koristi za razgradnju ugrušaka.
The active substance in Methylthioninium chloride Proveblue, methylthioninium chloride (also called methylene blue), helps speed up the conversion of abnormal haemoglobin back into normal haemoglobin.
Djelatna tvar lijeka Methylthioninium chloride Proveblue, metiltioninijev klorid (koji se također naziva u metilen plavi) pomaže pri ubrzavanju konverzije abnormalnog hemoglobina natrag u normalan hemoglobin.
The active substance in Micardis, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Telmisartan, djelatna tvar u lijeku Micardis, „antagonist je receptora angiotenzina II”, što znači da u tijelu blokira djelovanje hormona naziva angiotenzin II.
The active substance in Mirvaso, brimonidine tartrate, works by attaching to receptors called alpha2- adrenergic receptors on the cells of blood vessels of the skin and activating them.
Djelatna tvar lijeka Mirvaso, brimonidintartrat, djeluje tako što se veže na receptore naziva alfa2- adrenergički receptori na stanicama krvnih žila kože i aktivira ih.
The active substance in Myocet is doxorubicin HCl.
Djelatna tvar u lijeku Myocet je doksorubicin HCl.
The active substance in Naxcel is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatne tvari u Naxcelu navedene se u tablici 1 dodatka Uredbe Komisije (EU) br.
The active substance in Nevanac, nepafenac, is a ‘prodrug’ of amfenac.
Djelatna tvar u lijeku Nevanac, nepafenak, jest „predlijek” amfenaka.
The active substance in NexGard, afoxolaner, acts as an ‘ectoparasiticide’.
Djelatna tvar VMP-a NexGard, afoksolaner, djeluje kao „ektoparaziticid”.
The active substance in Nordimet, methotrexate, stops cells from growing too fast by interfering with the production of DNA.
Djelatna tvar u lijeku Nordimet, metotreksat, sprječava prebrzi rast stanica ometajući stvaranje DNK
The active substance in Novaquin is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Djelatna tvar Novaquina je dozvoljena tvar kako je opisano u tablici 1 Dodatka Uredbe Komisije (EU) br.
The active substance in NovoSeven, eptacog alfa (activated), is almost identical to a human protein called factor VII.
Djelatna tvar u lijeku NovoSeven, eptakog alfa (aktivirani), gotovo je istovjetna proteinu u čovjeka koji se naziva faktor VII.
The active substance in Noxafil is posaconazole.
Djelatna tvar u lijeku Noxafil je posakonazol.
The active substance in Nplate, romiplostim, is a medicine that stimulates the production of platelets.
Djelatna tvar lijeka Nplate, romiplostim, lijek je koji stimulira stvaranje trombocita.
The active substance in Nucala, mepolizumab, is a type of protein called a monoclonal antibody, which attaches to a specific substance in the body.
Djelatna tvar u lijeku Nucala, mepolizumab, vrsta je bjelančevine naziva monoklonsko protutijelo, koje se veže na posebnu tvar u tijelu.
The active substance in Nuwiq, simoctocog alfa, works in the body in the same way as human factor VIII.
Djelatna tvar u lijeku Nuwiq, simoktokog alfa djeluje u tijelu na isti način kao i čimbenik VIII.
The active substance in Olysio, simeprevir, blocks the action of an enzyme called ‘NS3/4A serine protease’ in the hepatitis C virus, which is essential for the virus to multiply.
Djelatna tvar lijeka Olysio, simeprevir, u virusu hepatitisa C inhibira djelovanje enzima „NS3/4A serin proteaza”, neophodnog za umnožavanje virusa.
The active substance in ONIVYDE is irinotecan (topoisomerase I inhibitor) encapsulated in a lipid bilayer vesicle or liposome.
Djelatna tvar lijeka ONIVYDE je irinotekan (inhibitor topoizomeraze I) inkapsuliran u vezikul s lipidnim dvoslojem, odnosno liposom.
The active substance in Onivyde, irinotecan, is a cancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Djelatna tvar lijeka Onivyde, irinotekan, lijek je protiv raka koji se ubraja u grupu „inhibitora topoizomeraze”.
The active substance in Opdivo, nivolumab, is a monoclonal antibody.
Djelatna tvar lijeka Opdivo, nivolumab, je monoklonalno protutijelo.
The active substance in Opsumit, macitentan, works by blocking ‘endothelin receptors’.
Djelatna tvar lijeka Opsumit, macitentan, djeluje blokirajući „receptore endotelina”.
The active substance in Optimark, gadoversetamide, contains gadolinium, a ‘rare-earth’ metal element.
Djelatna tvar u lijeku Optimark, gadoversetamid, sadrži gadolinij, rijetki zemni metal.
The active substance in Orencia, abatacept, is a protein that has been designed to suppress the activity of T cells, immune system cells that are involved in causing the inflammation in rheumatoid and polyarticular juvenile idiopathic arthritis.
Djelatna tvar lijeka Orencia, abatacept, je bjelančevina razvijena za suzbijanje aktivnosti T-stanica, stanica imunosnog sustava koje su jedan od uzroka upale u slučaju reumatoidnog i poliartikularnog juvenilnog idiopatskog artritisa.
The active substance in Ozurdex, dexamethasone, belongs to a group of anti-inflammatory medicines known as corticosteroids.
Djelatna tvar u lijeku Ozurdex, deksmetazon pripada skupini protuupalnih lijekova poznatih kao kortikosteroidi.
The active substance in Palonosetron Accord, palonosetron, is a ‘5HT3 antagonist’.
Djelatna tvar u lijeku Palonosetron Accord, palonosetron, jest „antagonist receptora 5HT3”.
The active substance in Palonosetron Hospira, palonosetron, is a ‘5HT3 antagonist’.
Djelatna tvar lijeka Palonosetron Hospira, palonosetron, je „antagonist receptora 5HT3”.
The active substance in Panacur AquaSol, fenbendazole, is a well-known anthelmintic, a substance that is active against helminths (parasitic worms).
Djelatna tvar VMP-a Panacur AquaSol, fenbendazol, poznati je anthelmintik, tvar koja je aktivna protiv helminta (parazitskih crva).
The active substance in PecFent, fentanyl, is an opioid.
Djelatna tvar lijeka PecFent, fentanil, je opioid.
The active substance in Pegasys, peginterferon alfa-2a, belongs to the group ‘interferons’.
Djelatna tvar u lijeku Pegasys, peginterferon alfa-2a pripada grupi „interferona”.
The active substance in Pemetrexed Accord, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Djelatna tvar lijeka Pemetrexed Accord, pemetreksed, citotoksičan je lijek (lijek koji uzrokuje smrt stanica koje se dijele, kao što su stanice raka) koji se ubraja u grupu „antimetabolita”.
The active substance in Pemetrexed Fresenius Kabi, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Djelatna tvar u lijeku Pemetrexed Fresenius Kabi, pemetreksed, citotoksičan je lijek (lijek koji uzrokuje smrt stanica koje se dijele kao što su stanice raka) koji se ubraja u skupinu „antimetabolita”.
The active substance in Pemetrexed Hospira, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Djelatna tvar lijeka Pemetrexed Hospira, pemetreksed, citotoksičan je lijek (lijek koji uzrokuje smrt stanica koje se dijele, kao što su stanice karcinoma), a ubraja se u grupu „antimetabolita”.
The active substance in Pemetrexed Lilly, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Djelatna tvar lijeka Pemetrexed Lilly, pemetreksed, citotoksičan je lijek (lijek koji uzrokuje smrt stanica koje se dijele, kao što su stanice karcinoma), a ubraja se u grupu „antimetabolita”.